Authors:
LIU C
NG JS
BEHLING JR
YEN CH
CAMPBELL AL
FUZAIL KS
YONAN EE
MEHROTRA DV
Citation: C. Liu et al., DEVELOPMENT OF A LARGE-SCALE PROCESS FOR AN HIV PROTEASE INHIBITOR, Organic process research & development, 1(1), 1997, pp. 45-54
Citation: Dv. Mehrotra, NONITERATIVE ROBUST ESTIMATORS OF VARIANCE-COMPONENTS IN WITHIN-SUBJECT DESIGNS, Statistics in medicine, 16(13), 1997, pp. 1465-1479
Authors:
WHITE WB
MEHROTRA DV
BLACK HR
FAKOUHI TD
ELLIOTT W
BYNNY RL
CARR AA
PRISANT M
GRIMM RH
HOGAN LB
KAIHLANEN PM
LEWIN A
MAXWELL MH
MERSEY JH
PRATT JH
PUNZI HA
ROSEN JB
SICA D
RIPLEY B
WALLIN JD
WEIDLER DJ
ESAYAGTENDER B
Citation: Wb. White et al., EFFECTS OF CONTROLLED-ONSET EXTENDED-RELEASE VERAPAMIL ON NOCTURNAL BLOOD-PRESSURE (DIPPERS VERSUS NONDIPPERS), The American journal of cardiology, 80(4), 1997, pp. 469-474
Authors:
GULLIKSON GW
LOEFFLER RF
MEHROTRA DV
CASLER JJ
BIANCHI RG
SCHMIDT RE
KHOSHABA N
PERKINS WE
Citation: Gw. Gullikson et al., POLYMERIC DELIVERY OF THE ACTIVE ISOMER OF MISOPROSTOL REDUCES SYSTEMIC AVAILABILITY AND UTEROTONIC ACTIVITY, The Journal of pharmacology and experimental therapeutics, 273(3), 1995, pp. 1123-1131
Authors:
SZALONY JA
HAAS NF
SALYERS AK
TAITE BB
NICHOLSON NS
MEHROTRA DV
FEIGEN LP
Citation: Ja. Szalony et al., EXTENDED INHIBITION OF PLATELET-AGGREGATION WITH THE ORALLY-ACTIVE PLATELET INHIBITOR SC-54684A, Circulation, 91(2), 1995, pp. 411-416
Authors:
SALYERS AK
SZALONY JA
TAITE BB
HAAS NF
MEHROTRA DV
FEIGEN LP
NICHOLSON NS
Citation: Ak. Salyers et al., A NEW METHOD FOR MEASUREMENT OF PLASMA-CONCENTRATION OF ORALLY-ACTIVEGLYCOPROTEIN IIB IIIA ANTAGONISTS/, Thrombosis research, 75(4), 1994, pp. 409-417
Authors:
PANZERKNODLE S
TAITE BB
MEHROTRA DV
NICHOLSON NS
FEIGEN LP
Citation: S. Panzerknodle et al., SPECIES VARIATION IN THE EFFECT OF GLYCOPROTEIN-IIB IIIA ANTAGONISTS ON INHIBITION OF PLATELET-AGGREGATION/, Journal of pharmacological and toxicological methods, 30(1), 1993, pp. 47-53